CSIMarket
 


Accelerate Diagnostics, Inc.  (AXDX)
Other Ticker:  
 
 

AXDX's Revenue Growth by Quarter and Year

Accelerate Diagnostics,'s Revenue results by quarter and year




AXDX Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 3.76 3.60 0.02
III Quarter September - 1.36 0.53 0.16
II Quarter June - 1.69 0.04 0.02
I Quarter March 1.75 0.80 0.02 0.09
FY   1.75 7.61 4.19 0.29



AXDX Revenue first quarter 2019 Y/Y Growth Comment
Accelerate Diagnostics, Inc. reported Revenue surge of 118.75% year on year in the first quarter, to $ 1.75 millions, this is lower than Accelerate Diagnostics, Inc.'s recent average Revenue surge of 583.08%.

According to the results reported in the first quarter, Accelerate Diagnostics, Inc. achieved the best Revenue growth in Laboratory Analytical Instruments industry. While Accelerate Diagnostics, Inc.' s Revenue doubling of 118.75% ranks overall at the positon no. 210 in the first quarter.




AXDX Revenue ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - 4.44 % 17900 % 0 %
III Quarter September - 156.6 % 231.25 % 1500 %
II Quarter June - 4125 % 100 % -75 %
I Quarter March 118.75 % 3900 % -77.78 % 350 %
FY   - 81.62 % 1344.83 % -

Financial Statements
Accelerate Diagnostics,'s first quarter 2019 Revenue $ 1.75 millions AXDX's Income Statement
Accelerate Diagnostics,'s first quarter 2018 Revenue $ 0.80 millions Quarterly AXDX's Income Statement
New: More AXDX's historic Revenue Growth >>


AXDX Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - 176.47 % 579.25 % -87.5 %
III Quarter September - -19.53 % 1225 % 700 %
II Quarter June - 111.25 % 100 % -77.78 %
I Quarter March -53.46 % -77.78 % 0 % 350 %
FY (Year on Year)   - 81.62 % 1344.83 % -




Revenue first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #1
Healthcare Sector #53
Overall #210

Revenue Y/Y Growth Statistics
High Average Low
9138.46 % 583.08 % -96.56 %
(Dec 31 2017)   (Jun 30 2013)
Revenue first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #1
Healthcare Sector #53
Overall #210
Revenue Y/Y Growth Statistics
High Average Low
9138.46 % 583.08 % -96.56 %
(Dec 31 2017)   (Jun 30 2013)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Accelerate Diagnostics,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1523.19 % 175.81 % -96.13 %
(Jul 31 2012)  


AXDX's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2019 Accelerate Diagnostics, Inc. realized fall in Revenue from the forth quarter by -53.46% to $ 1.75 millions, from $ 3.76 millions released in the previous qaurter.

But that's not important issue, as Revenue generally tend to slow in the I. Quarter.

Within Laboratory Analytical Instruments industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Accelerate Diagnostics,'s Revenue growth quarter on quarter, overall rank is 3326.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #23
Healthcare Sector #422
Overall #3326
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #23
Healthcare Sector #422
Overall #3326
Revenue Q/Q Growth Statistics
High Average Low
1523.19 % 175.81 % -96.13 %
(Jul 31 2012)  


AXDX's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2019 Accelerate Diagnostics, Inc. disclosed fall in Revenue from the previous quarter by -53.46% to $ 1.75 millions, from $ 3.76 millions declared in the previous qaurter.

When you look into recent downturn in the quarter, you suppose to presume, that commonly I. Quarter performance occur weaker relative to the preciding period

Within Laboratory Analytical Instruments industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Accelerate Diagnostics,'s Revenue growth quarter on quarter, overall rank is 3326.


Accelerate Diagnostics,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
Cumulative Revenue 12 Months Ending $ 8.56 $ 9.25 $ 7.45 $ 6.63 $ 4.97
Y / Y Revenue Growth (TTM) 72.09 % 3659.76 % 1115.5 % 2593.5 % 2071.62 %
Year on Year Revenue Growth Overall Ranking # 249 # 4 # 19 # 0 # 14
Seqeuential Revenue Change (TTM) 12.47 % 67.34 % 12.45 % 33.24 % 18.52 %
Seq. Revenue Growth (TTM) Overall Ranking # 255 # 46 # 144 # 0 # 156




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2019 period, Accelerate Diagnostics,'s cumulative twelve months Revenue were $ 9 millions, company would post below average annual Revenue growth of 18.52% year on year, if the fiscal year would end at Mar 31 2019.
A slow-down in the Accelerate Diagnostics,'s Revenue growth from the 3.76% growth in Dec 31 2018. Despite that, Accelerate Diagnostics, showed the highest Revenue growth, among it's peers in Laboratory Analytical Instruments industry.

In the Healthcare sector 69 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 4 to 249.

Revenue TTM Q/Q Growth Statistics
High Average Low
584.5 %
57.22 %
-27.94 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 1
Healthcare Sector # 70
Overall # 249

Revenue TTM Y/Y Growth Statistics
High Average Low
3659.76 %
590.87 %
-81.47 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 64
S&P 500 # 255
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2019 period, Accelerate Diagnostics,'s cumulative twelve months Revenue were $ 9 millions, company would post below average annual Revenue growth of -81.47% year on year, if the fiscal year would end at Mar 31 2019.
A slow-down in the Accelerate Diagnostics,'s Revenue growth from the 3.76% growth in Dec 31 2018. Despite that, Accelerate Diagnostics, showed the highest Revenue growth, among it's peers in Laboratory Analytical Instruments industry.

In the Healthcare sector 69 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 4 to 249.

Revenue TTM Q/Q Growth Statistics
High Average Low
584.5 %
57.22 %
-27.94 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 1
Healthcare Sector # 70
Overall # 249

Revenue TTM Y/Y Growth Statistics
High Average Low
3659.76 %
590.87 %
-81.47 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 64
S&P 500 # 255




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AXDX's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for AXDX's Competitors
Revenue Growth for Accelerate Diagnostics,'s Suppliers
Revenue Growth for AXDX's Customers

You may also want to know
AXDX's Annual Growth Rates AXDX's Profitability Ratios AXDX's Asset Turnover Ratio AXDX's Dividend Growth
AXDX's Roe AXDX's Valuation Ratios AXDX's Financial Strength Ratios AXDX's Dividend Payout Ratio
AXDX's Roa AXDX's Inventory Turnover Ratio AXDX's Growth Rates AXDX's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 31 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2019
Bionik Laboratories Corp.  203.85 %$ 203.848 millions
Mei Pharma, Inc.  188.45 %$ 188.453 millions
Pfenex Inc.  176.62 %$ 176.615 millions
Heron Therapeutics, Inc.  173.21 %$ 173.208 millions
Myomo Inc  165.05 %$ 165.045 millions
Myos Rens Technology Inc.  161.40 %$ 161.404 millions
Northwest Biotherapeutics Inc  156.82 %$ 156.818 millions
Fate Therapeutics Inc  156.53 %$ 156.530 millions
Tandem Diabetes Care Inc  141.94 %$ 141.944 millions
Beigene, Ltd.  139.16 %$ 139.162 millions
Accelerate Diagnostics, Inc.  118.48 %$ 118.477 millions
Techcare Corp.  117.69 %$ 117.690 millions
Eyepoint Pharmaceuticals, Inc.  116.81 %$ 116.810 millions
Wave Life Sciences Ltd.  112.80 %$ 112.799 millions
Cytomx Therapeutics, Inc.  107.88 %$ 107.875 millions
Yield10 Bioscience, Inc.  106.67 %$ 106.667 millions
Pieris Pharmaceuticals, Inc.  105.80 %$ 105.804 millions
Ionis Pharmaceuticals Inc  105.80 %$ 105.800 millions
Radius Health, Inc.  105.16 %$ 105.156 millions
Corindus Vascular Robotics, Inc.  104.44 %$ 104.444 millions
Amicus Therapeutics, Inc.  103.92 %$ 103.917 millions
Vilacto Bio Inc.  103.61 %$ 103.613 millions
Akers Biosciences, Inc.  102.37 %$ 102.371 millions
Vbi Vaccines Inc  102.25 %$ 102.247 millions
Dicerna Pharmaceuticals Inc  101.10 %$ 101.100 millions
Corbus Pharmaceuticals Holdings, Inc.  98.40 %$ 98.401 millions
Jaguar Health, Inc.  97.64 %$ 97.640 millions
Neurocrine Biosciences Inc  94.70 %$ 94.698 millions
Precision Optics Corporation, Inc.  88.48 %$ 88.480 millions
Inovio Pharmaceuticals, Inc.  85.00 %$ 85.004 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NNVC's Profile

Stock Price

NNVC's Financials

Business Description

Fundamentals

Charts & Quotes

NNVC's News

Suppliers

NNVC's Competitors

Customers & Markets

Economic Indicators

NNVC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071